Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
12/11/2002 | CN1384887A Converting diplidy to haploidy for genetic diagnosis |
12/11/2002 | CN1384884A Herpes virus vectors for dendritic cells |
12/11/2002 | CN1384882A Fatty acid desaturase gene from plants |
12/11/2002 | CN1384881A Compositions and methods for non-targeted activation of endogenous genes |
12/11/2002 | CN1384879A peroxidase genomic gene derived from ipomoea batatas and promoter thereof |
12/11/2002 | CN1384878A IREN protein, its preparation and use |
12/11/2002 | CN1384877A Rescue of mumps virus from cDNA |
12/11/2002 | CN1384875A Polypeptides having glucanotransferase activity and nucleic acids encoding same |
12/11/2002 | CN1384759A Single-stranded oligodeoxynucleotide mutional vectors |
12/11/2002 | CN1384757A Method for down-regulating GDF-8 activity |
12/11/2002 | CN1384198A Method of obtaining transgenic plant capable of expressing human somatomedin gene |
12/11/2002 | CN1384192A Rice 5-enolpyruvate shikimate-3-phosphorylase and gene encoding this phosphrylase |
12/10/2002 | US6492578 Plastid expression constructs include a plastid promoter region capable of providing for enhanced expression of a dna sequence, a dna sequence encoding an epsps protein or hgh, and a transcription termination region |
12/10/2002 | US6492577 Nucleic acids are useful in targeting gene expression to embryos or in modulating embryo development in plants |
12/10/2002 | US6492575 Method for developing transgenic mice |
12/10/2002 | US6492511 Isolation and identification of novel polymerases |
12/10/2002 | US6492509 Fatty acyl-CoA: fatty alcohol acyltransferases |
12/10/2002 | US6492507 Polynucleotides encoding human eosinophil-derived basic protein |
12/10/2002 | US6492499 Human pancreatitis-associated protein |
12/10/2002 | US6492493 Bone morphogenetic protein (BMP)-17 and BMP-18 compositions |
12/10/2002 | US6492343 Porcine adenovirus type 3 genome |
12/10/2002 | US6492331 NL8 tie ligands homologues |
12/10/2002 | US6492174 Placing explant in liquid medium comprising auxins, cytokinins, and nutrients |
12/10/2002 | US6492171 Antisense modulation of TERT expression |
12/10/2002 | US6492169 Complementing cell lines |
12/10/2002 | US6492167 Membrane protein for use in the treatnment of diabetes, hypotension, endocrine defects |
12/10/2002 | US6492164 Circular DNA expression cassettes for gene transfer |
12/10/2002 | US6492163 Cell culture tube and multiple roller tube cell culture system using the same |
12/10/2002 | US6492161 Bacteriophage RM 378 of a thermophilic host organism |
12/10/2002 | US6492157 Methods are provided for the treatment of conditions associated with cells proliferation, cells differentiation and cell survival. in particular, the dual-specificity phosphatase dsp-9, and polypeptide variants thereof that |
12/10/2002 | US6492151 The invention provides isolated nucleic acid and amino acid sequences of hskip3d, antibodies to hskip3d, methods of screening for hskip3d modulators using biologically active hskip3d, and kits for screening for hskip3d modulators. |
12/10/2002 | US6492148 A method for the preparation of an infectious ibdv mutant which will replicate in cef cell culture, comprising: separately preparing a dna construct comprising cdna of genome segments a and b of an ibdv which is not capable of |
12/10/2002 | US6492145 Vaccine against mycobacterial infections |
12/10/2002 | US6492137 Response element compositions and assays employing same |
12/10/2002 | US6492126 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
12/10/2002 | US6492119 Film-shaped material, which is not apt to suffer from bending and creasing, is used as a base material, such that the macro array is easy to process |
12/10/2002 | US6492104 EIA test using nondenatured HIV antigen for early detection of HIV infection |
12/10/2002 | US6491926 35 kD tumor associated protein antigen: uses and methods of detection |
12/10/2002 | US6491918 Antibody compositions for preparing enriched dendritic cell preparations |
12/10/2002 | US6491917 Antibody composition for debulking blood and bone marrow samples from CML patients |
12/10/2002 | US6491915 Anti-CCR2 antibodies and methods of use therefor |
12/10/2002 | US6491912 Porcine cardiomyocytes and their use in treatment of insufficient cardiac function |
12/10/2002 | US6491909 Blocking antigen expression in genes of the major histocompatibility complex to prevent graft versus host dieases after grafting islets of langerhans; prophylaxis of diabetes mellitus |
12/10/2002 | US6491908 Selective elimination of T cells that recognize specific preselected targets |
12/10/2002 | US6491907 Genetic engineered chimera particles comprising capsids from adeno-associated virus and genome inverted terminal repeat sequences as vectors for supplying and expressing nucleotide sequence in cells |
12/10/2002 | CA2212150C Monoclonal antibodies for human osteogenic cell surface antigens |
12/10/2002 | CA2196085C Mhc complexes and uses thereof |
12/10/2002 | CA2114015C Recombinant antibodies for human therapy |
12/10/2002 | CA2077764C Antibody to pacap and use thereof |
12/10/2002 | CA1341407C Minactivin |
12/07/2002 | CA2390085A1 Metabolic biosensor and uses thereof |
12/05/2002 | WO2002097395A2 P-cadherin as a target for anti-cancer therapy |
12/05/2002 | WO2002097128A2 Method for identifying substances directed against myocardial cell hypertrophy |
12/05/2002 | WO2002097121A1 Method for assaying osteoclast recruitment and resorption |
12/05/2002 | WO2002097120A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
12/05/2002 | WO2002097110A2 TUMOR ENDOTHELIAL MARKER 7α MOLECULES AND USES THEREOF |
12/05/2002 | WO2002097104A1 Pseudotyping vih-1 vectors with the aid of rhabdovirus envelopes |
12/05/2002 | WO2002097103A2 Constitutive plant promotor |
12/05/2002 | WO2002097102A2 Modification of plant genomes by inducible site-specific recombination of trans genes |
12/05/2002 | WO2002097101A1 Transgenic plants with reduced adenylate kinase activity showing an increased accumulation of starch |
12/05/2002 | WO2002097094A1 Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis |
12/05/2002 | WO2002097087A1 Method of expressing foreign gene in kidney |
12/05/2002 | WO2002097085A2 Callus specific plant promoters |
12/05/2002 | WO2002097079A2 Gene encoding molecular motor protein and diagnosis method for the disease related to the gene |
12/05/2002 | WO2002097075A2 Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties |
12/05/2002 | WO2002097071A1 Revertant cells from a breast tumour |
12/05/2002 | WO2002097070A1 Ex-vivo isolated cd25+cd4+ t cells with immunosuppressive activity and uses thereof |
12/05/2002 | WO2002097069A1 Purification of lineage-specific cells and uses therefor |
12/05/2002 | WO2002097068A2 Keratinocytes obtained from embryonic stem cells of mammals |
12/05/2002 | WO2002097067A1 A method of purification of cells |
12/05/2002 | WO2002097066A2 Human vascular progenitor cells |
12/05/2002 | WO2002097065A2 Remodeling of somatic nuclei upon addition of pluripotent cell extracts |
12/05/2002 | WO2002097060A2 Carbohydrate-associated proteins |
12/05/2002 | WO2002097059A2 Chromosome-based platforms |
12/05/2002 | WO2002097050A2 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions |
12/05/2002 | WO2002097046A2 B7 related protein-2 molecules and uses thereof |
12/05/2002 | WO2002097045A2 Neuroblastoma cell lines expressing the alpha2delta subunit of calcium channels and methods therefore |
12/05/2002 | WO2002097044A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
12/05/2002 | WO2002097043A2 Wnv core protein/capsid interacting protein and uses of the same |
12/05/2002 | WO2002097035A2 Secreted proteins |
12/05/2002 | WO2002097033A2 Antibodies that immunospecifically bind to trail receptors |
12/05/2002 | WO2002097032A2 Proteins associated with cell growth, differentiation, and death |
12/05/2002 | WO2002097029A2 Plate and method for high throughput screening |
12/05/2002 | WO2002096952A2 Conjugate of a transport protein and a protein for modulation of notch signalling |
12/05/2002 | WO2002096951A1 Molecules for disease detection and treatment |
12/05/2002 | WO2002096947A2 The lectin-like domain of thrombomodulin and its therapeutic use |
12/05/2002 | WO2002096946A1 Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy30 |
12/05/2002 | WO2002096942A2 Recombinant dna encoding the major allergen of plantago lanceolata pollen pla l 1, and applications thereof |
12/05/2002 | WO2002096939A2 Adenovirus protein ix, its domains involved in capsid assembly, transcriptional activity and nuclear reorganization |
12/05/2002 | WO2002096932A1 Transporters and ion channels |
12/05/2002 | WO2002096924A1 Kindling fluorescent proteins and methods for their use |
12/05/2002 | WO2002096923A1 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes |
12/05/2002 | WO2002096439A1 Use of haematopoietic stem cells in the generation of neural stem cells |
12/05/2002 | WO2002096364A2 Feline bronchioloalveolar lung carcinoma xenograft and cell line |
12/05/2002 | WO2002096263A2 Eb matrix production from fetal tissues and its use for tissue repair |
12/05/2002 | WO2002096203A1 Stem cell differentiation |
12/05/2002 | WO2002096195A1 Treatment or replacement therapy using transgenic stem cells delivered to the gut |
12/05/2002 | WO2002087499A9 Cells for detection of enteroviruses |
12/05/2002 | WO2002070557A3 Nuclear hormone receptor ligand binding domain |
12/05/2002 | WO2002068470A3 Interferon-alpha induced gene |